par Body, Jean-Jacques 
Référence Expert review of anticancer therapy, 12, 3, page (307-322)
Publication Publié, 2012-03
Référence Expert review of anticancer therapy, 12, 3, page (307-322)
Publication Publié, 2012-03
Article révisé par les pairs
| Titre: |
|
| Auteur: | Body, Jean-Jacques |
| Informations sur la publication: | Expert review of anticancer therapy, 12, 3, page (307-322) |
| Statut de publication: | Publié, 2012-03 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | bone metastases |
| denosumab | |
| skeletal-related events | |
| supportive care | |
| zoledronic acid | |
| MeSH keywords: | Antibodies, Monoclonal -- administration & dosage -- adverse effects -- pharmacokinetics |
| Antibodies, Monoclonal, Humanized | |
| Biological Availability | |
| Bone Density Conservation Agents -- administration & dosage -- adverse effects -- pharmacokinetics | |
| Bone Neoplasms -- metabolism -- pathology -- secondary -- therapy | |
| Bone Remodeling -- drug effects | |
| Bone and Bones -- drug effects -- metabolism -- pathology | |
| Clinical Trials as Topic | |
| Diphosphonates -- administration & dosage -- adverse effects -- pharmacokinetics | |
| Disease Management | |
| Humans | |
| Imidazoles -- administration & dosage -- adverse effects -- pharmacokinetics | |
| Immunologic Factors -- administration & dosage -- adverse effects -- pharmacokinetics | |
| Neoplasm Metastasis | |
| Neoplasms -- pathology | |
| Outcome Assessment (Health Care) | |
| Palliative Care -- methods | |
| RANK Ligand -- metabolism | |
| Receptor Activator of Nuclear Factor-kappa B -- metabolism | |
| Note générale: | Journal Article |
| Review | |
| SCOPUS: re.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1473-7140 |
| info:doi/10.1586/era.11.204 | |
| info:scp/84857852442 | |
| info:pmid/22192269 |
